$53.43
0.210.39%
At close: -
$53.50
0.070.13%
After Hours: 7:53 PM EDT
Comments
Loading...
Dutch Bros Analyst Ratings and Price Targets | NYSE:BROS | Benzinga
Dutch Bros Inc has a consensus price target of $77.9 based on the ratings of 20 analysts. The high is $90 issued by Wedbush on March 31, 2025. The low is $63 issued by Piper Sandler on November 6, 2025. The 3 most-recent analyst ratings were released by Piper Sandler, RBC Capital, and Barclays on November 6, 2025, respectively. With an average price target of $70 between Piper Sandler, RBC Capital, and Barclays, there's an implied 30.84% upside for Dutch Bros Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
RBC Capital
Barclays
Stifel
Mizuho
1calculated from analyst ratings
Analyst Ratings for Dutch Bros
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/06/2025 | 17.76% | Piper Sandler | $73 → $63 | Maintains | Neutral | |||
11/06/2025 | 40.19% | RBC Capital | $85 → $75 | Maintains | Outperform | |||
11/06/2025 | 34.58% | Barclays | $65 → $72 | Maintains | Overweight | |||
10/31/2025 | 40.19% | Stifel | $82 → $75 | Maintains | Buy | |||
10/28/2025 | 30.84% | Mizuho | → $70 | Initiates | → Outperform | |||
10/22/2025 | 60.75% | Morgan Stanley | $84 → $86 | Maintains | Overweight | |||
10/22/2025 | 21.5% | Barclays | $92 → $65 | Maintains | Overweight | |||
10/16/2025 | 30.84% | Wells Fargo | $80 → $70 | Maintains | Overweight | |||
09/30/2025 | 34.58% | Goldman Sachs | $81 → $72 | Maintains | Neutral | |||
09/24/2025 | 58.88% | RBC Capital | $85 → $85 | Reiterates | Outperform → Outperform | |||
08/28/2025 | 58.88% | UBS | $80 → $85 | Maintains | Buy | |||
08/19/2025 | 60.75% | TD Cowen | $86 → $86 | Reiterates | Buy → Buy | |||
08/07/2025 | 60.75% | TD Cowen | $86 → $86 | Reiterates | Buy → Buy | |||
08/07/2025 | 57.01% | Morgan Stanley | $80 → $84 | Maintains | Overweight | |||
08/07/2025 | 58.88% | RBC Capital | $83 → $85 | Maintains | Outperform | |||
08/07/2025 | 42.06% | Guggenheim | $72 → $76 | Maintains | Buy | |||
08/07/2025 | 71.96% | Barclays | $84 → $92 | Maintains | Overweight | |||
08/07/2025 | 57.01% | B of A Securities | $80 → $84 | Maintains | Overweight | |||
07/17/2025 | 57.01% | Barclays | $82 → $84 | Maintains | Overweight | |||
06/30/2025 | 49.53% | CICC | → $80 | Initiates | → Outperform | |||
06/26/2025 | 40.19% | Goldman Sachs | → $75 | Initiates | → Neutral | |||
05/14/2025 | 55.14% | RBC Capital | → $83 | Initiates | → Outperform | |||
05/08/2025 | 53.27% | Barclays | $76 → $82 | Maintains | Overweight | |||
05/08/2025 | 17.76% | Piper Sandler | $70 → $63 | Maintains | Neutral | |||
05/08/2025 | 53.27% | Stifel | $85 → $82 | Maintains | Buy | |||
05/08/2025 | 34.58% | Baird | $66 → $72 | Maintains | Outperform | |||
05/08/2025 | 45.79% | TD Securities | $78 → $78 | Reiterates | Buy → Buy | |||
05/05/2025 | 49.53% | UBS | $90 → $80 | Maintains | Buy | |||
04/22/2025 | 42.06% | Barclays | $94 → $76 | Maintains | Overweight | |||
04/07/2025 | 23.36% | Baird | $80 → $66 | Maintains | Outperform | |||
03/31/2025 | 34.58% | Guggenheim | $54 → $72 | Maintains | Buy | |||
03/31/2025 | 68.22% | Wedbush | $90 → $90 | Reiterates | Outperform → Outperform | |||
03/28/2025 | 66.35% | TD Securities | $89 → $89 | Reiterates | Buy → Buy | |||
03/26/2025 | 49.53% | Wells Fargo | → $80 | Initiates | → Overweight | |||
03/24/2025 | 53.27% | Morgan Stanley | → $82 | Initiates | → Overweight | |||
02/28/2025 | 58.88% | Stifel | $74 → $85 | Maintains | Buy | |||
02/13/2025 | 49.53% | JP Morgan | $58 → $80 | Maintains | Overweight | |||
02/13/2025 | 30.84% | Piper Sandler | $51 → $70 | Maintains | Neutral | |||
02/13/2025 | 38.32% | Stifel | $62 → $74 | Maintains | Buy | |||
02/13/2025 | 68.22% | UBS | $67 → $90 | Maintains | Buy | |||
02/13/2025 | 77.57% | Baird | $70 → $95 | Maintains | Outperform | |||
02/13/2025 | 86.92% | Wedbush | $65 → $100 | Maintains | Outperform | |||
02/13/2025 | 66.35% | TD Securities | $65 → $89 | Maintains | Buy | |||
01/27/2025 | 34.58% | B of A Securities | $61 → $72 | Maintains | Buy | |||
01/15/2025 | 28.97% | Jefferies | $60 → $69 | Maintains | Buy | |||
01/13/2025 | 25.23% | UBS | $65 → $67 | Maintains | Buy | |||
01/10/2025 | 15.89% | Stifel | $53 → $62 | Maintains | Buy | |||
01/07/2025 | 30.84% | Barclays | $38 → $70 | Upgrade | Equal-Weight → Overweight | |||
01/06/2025 | 30.84% | Baird | $60 → $70 | Upgrade | Neutral → Outperform | |||
12/19/2024 | 8.41% | JP Morgan | $48 → $58 | Maintains | Overweight | |||
12/16/2024 | 12.15% | Jefferies | $45 → $60 | Maintains | Buy | |||
12/06/2024 | 21.5% | UBS | $44 → $65 | Maintains | Buy | |||
11/14/2024 | -0.93% | Stifel | $42 → $53 | Maintains | Buy | |||
11/11/2024 | -4.67% | Piper Sandler | $36 → $51 | Maintains | Neutral | |||
11/08/2024 | -28.97% | Barclays | $31 → $38 | Maintains | Equal-Weight | |||
11/07/2024 | -4.67% | B of A Securities | $49 → $51 | Maintains | Buy | |||
11/07/2024 | -10.28% | JP Morgan | $44 → $48 | Maintains | Overweight | |||
11/07/2024 | -14.02% | Baird | $37 → $46 | Maintains | Neutral | |||
11/07/2024 | -17.76% | UBS | $39 → $44 | Maintains | Buy | |||
11/07/2024 | 2.8% | Wedbush | $45 → $55 | Maintains | Outperform | |||
11/07/2024 | -0.93% | TD Cowen | $47 → $53 | Maintains | Buy | |||
10/14/2024 | -15.89% | Wedbush | $45 → $45 | Reiterates | Outperform → Outperform | |||
09/12/2024 | -12.15% | TD Cowen | $47 → $47 | Reiterates | Buy → Buy | |||
08/19/2024 | -32.71% | Piper Sandler | $41 → $36 | Downgrade | Overweight → Neutral | |||
08/15/2024 | -27.1% | UBS | → $39 | Upgrade | Neutral → Buy | |||
08/09/2024 | -42.06% | Barclays | $35 → $31 | Maintains | Equal-Weight | |||
08/08/2024 | -28.97% | Stifel | $40 → $38 | Maintains | Buy | |||
08/08/2024 | -15.89% | Wedbush | $45 → $45 | Reiterates | Outperform → Outperform | |||
08/08/2024 | -30.84% | Baird | $42 → $37 | Maintains | Neutral | |||
08/08/2024 | -12.15% | TD Cowen | $50 → $47 | Maintains | Buy | |||
07/11/2024 | -32.71% | Guggenheim | $30 → $36 | Maintains | Neutral | |||
07/03/2024 | -21.5% | Baird | $33 → $42 | Maintains | Neutral | |||
06/18/2024 | -6.54% | TD Cowen | $50 → $50 | Reiterates | Buy → Buy | |||
06/13/2024 | -6.54% | TD Cowen | $46 → $50 | Maintains | Buy | |||
06/10/2024 | -8.41% | B of A Securities | $44 → $49 | Maintains | Buy | |||
06/05/2024 | -14.02% | TD Cowen | $46 → $46 | Reiterates | Buy → Buy | |||
06/03/2024 | -17.76% | JP Morgan | $40 → $44 | Maintains | Overweight | |||
05/16/2024 | -15.89% | Wedbush | $39 → $45 | Maintains | Outperform | |||
05/10/2024 | -14.02% | TD Cowen | $33 → $46 | Upgrade | Hold → Buy | |||
05/08/2024 | -34.58% | Barclays | $30 → $35 | Maintains | Equal-Weight | |||
05/08/2024 | -27.1% | Wedbush | $37 → $39 | Maintains | Outperform | |||
04/26/2024 | -38.32% | TD Cowen | $33 → $33 | Reiterates | Hold → Hold | |||
04/12/2024 | -38.32% | TD Cowen | $33 → $33 | Reiterates | Hold → Hold | |||
04/11/2024 | -38.32% | TD Cowen | $33 → $33 | Reiterates | Hold → Hold | |||
04/10/2024 | -30.84% | Wedbush | $37 → $37 | Reiterates | Outperform → Outperform | |||
04/10/2024 | -38.32% | TD Cowen | $33 → $33 | Reiterates | Hold → Hold | |||
04/05/2024 | -43.93% | Guggenheim | $30 → $30 | Reiterates | Neutral → Neutral | |||
04/03/2024 | -30.84% | Wedbush | $37 → $37 | Reiterates | Outperform → Outperform | |||
04/03/2024 | -25.23% | Stifel | $40 → $40 | Maintains | Buy | |||
03/19/2024 | -25.23% | JP Morgan | $34 → $40 | Maintains | Overweight | |||
03/04/2024 | -30.84% | Piper Sandler | $32 → $37 | Upgrade | Neutral → Overweight | |||
02/22/2024 | -38.32% | TD Cowen | $33 → $33 | Reiterates | Market Perform → Market Perform | |||
02/22/2024 | -30.84% | Wedbush | $37 → $37 | Reiterates | Outperform → Outperform | |||
02/22/2024 | -43.93% | Barclays | $31 → $30 | Maintains | Equal-Weight | |||
01/16/2024 | -34.58% | Stifel | $32 → $35 | Upgrade | Hold → Buy | |||
01/03/2024 | -42.06% | Barclays | $28 → $31 | Maintains | Equal-Weight | |||
12/21/2023 | -30.84% | Wedbush | $35 → $37 | Maintains | Outperform | |||
11/20/2023 | -34.58% | JP Morgan | $30 → $35 | Upgrade | Neutral → Overweight | |||
11/08/2023 | -34.58% | Wedbush | $31 → $35 | Maintains | Outperform | |||
11/03/2023 | -42.06% | Wedbush | $37 → $31 | Maintains | Outperform |
FAQ
What is the target price for Dutch Bros (BROS) stock?
The latest price target for Dutch Bros (NYSE:BROS) was reported by Piper Sandler on November 6, 2025. The analyst firm set a price target for $63.00 expecting BROS to rise to within 12 months (a possible 17.76% upside). 54 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Dutch Bros (BROS)?
The latest analyst rating for Dutch Bros (NYSE:BROS) was provided by Piper Sandler, and Dutch Bros maintained their neutral rating.
When was the last upgrade for Dutch Bros (BROS)?
The last upgrade for Dutch Bros Inc happened on January 7, 2025 when Barclays raised their price target to $70. Barclays previously had an equal-weight for Dutch Bros Inc.
When was the last downgrade for Dutch Bros (BROS)?
The last downgrade for Dutch Bros Inc happened on August 19, 2024 when Piper Sandler changed their price target from $41 to $36 for Dutch Bros Inc.
When is the next analyst rating going to be posted or updated for Dutch Bros (BROS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dutch Bros, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dutch Bros was filed on November 6, 2025 so you should expect the next rating to be made available sometime around November 6, 2026.
Is the Analyst Rating Dutch Bros (BROS) correct?
While ratings are subjective and will change, the latest Dutch Bros (BROS) rating was a maintained with a price target of $73.00 to $63.00. The current price Dutch Bros (BROS) is trading at is $53.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
